Perceptive Advisors’s Immunogen Inc IMGN Stock Holding History

Perceptive Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-600,000	Closed	-$15K	–	120
2019 Q1	$15K	Buy	+600,000	New	+$2.6M	﹤0.01%	105

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors's IMGN Position: Q4 2017 in Review

Perceptive Advisors sold out of Immunogen Inc (IMGN) in Q4 2017, closing a stake of 70,126 shares — an estimated $536K sold.

Perceptive Advisors first reported a position in IMGN in Q2 2016 and held it in 2 quarters. The position peaked at $536K in Q3 2017. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2017.

Perceptive Advisors reported no remaining Immunogen Inc position as of Q4 2017 after selling out during the quarter.
Perceptive Advisors sold 70,126 Immunogen Inc shares in Q4 2017, an estimated $536K.
Perceptive Advisors first reported a position in Immunogen Inc in Q2 2016 and held it in 2 quarters.
Perceptive Advisors's Immunogen Inc position peaked at $536K in Q3 2017.
200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2017.

Based on Perceptive Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.